{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:41:14Z","timestamp":1776728474826,"version":"3.51.2"},"reference-count":44,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2026.2656072","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:05:31Z","timestamp":1776726331000},"page":"1213-1229","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness analysis of capivasertib plus fulvestrant in the\n                    <i>PIK3CA\/AKT1\/PTEN<\/i>\n                    -altered subgroup with HR+\/HER2\u2212 advanced breast cancer: a United States payer perspective"],"prefix":"10.1080","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7649-3896","authenticated-orcid":false,"given":"Xi","family":"Liang","sequence":"first","affiliation":[{"name":"Department of Pharmacotherapy, College of Pharmacy, University of Utah","place":["Salt Lake City, UT, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5006-9394","authenticated-orcid":false,"given":"Daniel C.","family":"Malone","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, College of Pharmacy, University of Utah","place":["Salt Lake City, UT, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2452-0556","authenticated-orcid":false,"given":"Chia Jie","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, College of Pharmacy, University of Utah","place":["Salt Lake City, UT, USA"]},{"name":"Cancer Control and Population Sciences Program, Huntsman Cancer Institute","place":["Salt Lake City, UT, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"National Cancer Institute. Cancer stat facts. Surveillance epidemiology and end results (SEER) program. 2025 [cited 2025 Aug 18]. Available from: https:\/\/seer.cancer.gov\/statfacts\/"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2022.07.006"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.03.015"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkab063"},{"key":"e_1_3_5_6_1","unstructured":"National Cancer Institute. Female breast cancer subtypes. The National Cancer Institute\u2019s Surveillance Epidemiology And End Results (SEER) program; 2025 [cited 2025 Aug 18]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/breast-subtypes.html"},{"key":"e_1_3_5_7_1","unstructured":"National Comprehensive Cancer Network (NCCN). Breast cancer guidelines. Version. 2023. 2025 [cited 2025 Aug 18]. Available from: www.NCCN.com"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00360-5"},{"key":"e_1_3_5_9_1","unstructured":"U.S Food & Drug Administration. FDA approves capivasertib with fulvestrant for breast cancer. 2023. [cited 2025 September 25]; Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-capivasertib-fulvestrant-breast-cancer"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00284-4"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2214131"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00948-1"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-024-01456-x"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1495082"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.11.1351"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.12195"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-9"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1109\/TAC.1974.1100705"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01701-9"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.011"},{"key":"e_1_3_5_21_1","unstructured":"U.S. Bureau of Labor Statistics. Consumer price index (CPI) databases; 2025 [cited 2025 Oct 05]. Available from: https:\/\/www.bls.gov\/cpi\/data.htm"},{"key":"e_1_3_5_22_1","unstructured":"Wong W Carlson J Cloutier M. Estimating the costs of adverse events in economic models: is there a \u201cright\u201d approach? 2019 [cited 2026 Jan 31]. Available from: fromhttps:\/\/www.ispor.org\/publications\/journals\/value-outcomes-spotlight\/"},{"key":"e_1_3_5_23_1","unstructured":"U.S. Centers for Medicare & Medicaid Services. Medicare part B drug average sales price 2025 [cited 2025 Oct 05]. Available from: https:\/\/www.cms.gov\/medicare\/payment\/fee-for-service-providers"},{"key":"e_1_3_5_24_1","unstructured":"Merative. Micromedex red book. 2025 [cited 2025 Oct 05]. Available from: https:\/\/www.merative.com\/documents\/micromedex-red-book"},{"key":"e_1_3_5_25_1","unstructured":"U.S. Centers for Medicare & Medicaid Services. Medicare physician fee schedule; 2025 [cited 2025 Oct 05]. Available from: https:\/\/www.cms.gov\/medicare\/payment\/fee-schedules\/physician"},{"key":"e_1_3_5_26_1","unstructured":"U.S. Centers for Medicare & Medicaid Services. Medicare clinical laboratory fee schedule; 2025 [cited 2025 Oct 06]. Available from: https:\/\/www.cms.gov\/medicare\/payment\/fee-schedules\/clinical-laboratory-fee-schedule-clfs"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196007"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.5604\/12321966.1235168"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2015.04.001"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1017\/S026646231100064X"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0689-x"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2010.483508"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00373-5"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1098-3015(10)72194-X"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603326"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-023-01325-z"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-6-84"},{"key":"e_1_3_5_38_1","unstructured":"Ken O Mezzio DJ. Demystifying ICER\u2019s equal value of life years gained metric. 2021 [cited 2025 Oct 10]. Available from: https:\/\/www.ispor.org\/publications\/journals\/value-outcomes-spotlight\/"},{"key":"e_1_3_5_39_1","unstructured":"Institute for Clinical and Economic Review. The 2023 value assessment framework. 2023 [cited 2025 Oct 05]. Available from: https:\/\/icer.org\/our-approach\/methods-process\/value-assessment-framework\/"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta20540"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.3747\/co.25.3765"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103697"},{"key":"e_1_3_5_43_1","unstructured":"Institute for Clinical and Economic review (ICER). Cost-effectiveness the QALY and the evLY; [cited 2025 Sept 29]. Available from: https:\/\/icer.org\/our-approach\/methods-process\/cost-effectiveness-the-qaly-and-the-evlyg\/"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-023-01302-6"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02086"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2656072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:05:34Z","timestamp":1776726334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2026.2656072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2026.2656072"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2026.2656072","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}